Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts.
Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts.
复制标题
DOI:
10.1097/mpa.0b013e318232e130
复制
发表时间:
2012-05
期刊:
影响因子:
2.9
通讯作者:
Go VL
中科院分区:
文献类型:
--
作者:
Lu QY;Zhang L;Moro A;Chen MC;Harris DM;Eibl G;Go VL
Scutellaria baicalensis has been a subject of research interests due to its potential multiple therapeutic benefits. This study was to examine the distribution of baicalein, wogonin, oroxylin A and their glucuronide/sulfate conjugated metabolites in plasma, colon, small intestine, lung, liver, pancreas, kidney, and prostate tissues and in pancreatic tumor in a xenograft animal model. In addition, we examined metabolic stability of baicalin in these tissues. A mouse xenograft model was prepared by injection of 3×106 human pancreatic cancer MiaPaCa-2 cells subcutaneously into nude mice. Mice were randomly allocated to control diet (AIN76A) and 1% SB diet (n=8 per group) for 13 weeks. Levels of baicalein, wogonin, oroxylin A, and their conjugates in mouce tissues were measured by high-pressure liquid chromatography following enzymatic hydrolysis and then extraction. A substantial amount of baicalin (34–63%) was methylated to oroxylin A and its conjugates in various organs during absorption. While plasma contained predominantly conjugates of baicalein, wogonin, and oroxylin A, both aglycones and conjugates were found in all other tissues investigated and in tumor. Substantial accumulation of bioactive metabolites are found in target tissues, suggesting strong potential for SB use as a preventive or adjuvant supplement for pancreatic cancer.